Showing 1 - 20 results of 20,788 for search '(( e fold decrease ) OR ((( 69 _ decrease ) OR ( 50 ((a decrease) OR (nn decrease)) ))))', query time: 0.59s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD<sub>50</sub> = 8.4 μM, p ≤ 0.05). …”
  6. 6
  7. 7
  8. 8

    Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

    Published 2020
    “…At baseline, median hsTnI was 1.9 pg/mL and ranged from 0 to 69.6 pg/mL. Five patients (3.5%) had a high hsTnI value that exceeded 26.2 pg/mL, which is used as the cutoff for diagnosis of myocardial infarction, and 22 patients (15.4%) had an intermediate value between 5.0 and 26.2 pg/mL. …”
  9. 9
  10. 10
  11. 11

    <i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

    Published 2021
    “…The most striking difference was found in KO-F mice (35.51-fold increase in SLAM cells as compared to KO-F CD45.2<sup>+</sup> donor cells in whole BM, p = 0.0430). …”
  12. 12

    Map of spatial GPoE folds and predictive ability by fold. by Forrest Li (21512582)

    Published 2025
    “…<p>Correlations between genetics and environment are demonstrated through prediction but decrease when considering spatial distance. <b>A)</b> Map of sampled cross-validation folds used in spatial GPoE. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”